Ping Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ping Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,000	Closed	-$244K	–	97
2025 Q4	$244K	Sell	2,000 -1,000	-33%	-$115K	0.07%	65
2025 Q3	$301K	Sell	3,000 -3,000	-50%	-$270K	0.1%	60
2025 Q2	$498K	Buy	6,000 +300	+5%	+$23.9K	0.12%	55
2025 Q1	$462K	Buy	5,700 +2,700	+90%	+$241K	0.17%	61
2024 Q4	$270K	Hold	3,000	–	–	0.07%	72
2024 Q3	$296K	Hold	3,000	–	–	0.08%	72
2024 Q2	$278K	Buy	+3,000	New	+$269K	0.08%	64

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ping Capital Management's XBI Position: Q1 2026 in Review

Ping Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 2,000 shares — an estimated $244K sold.

Ping Capital Management first reported a position in XBI in Q2 2024 and held it in 7 quarters. The position peaked at $498K in Q2 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Ping Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
Ping Capital Management sold 2,000 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $244K.
Ping Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and held it in 7 quarters.
Ping Capital Management's State Street SPDR S&P Biotech ETF position peaked at $498K in Q2 2025.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Ping Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.